Cranfield Health, Cranfield University, UK.
Anal Chim Acta. 2011 Dec 5;708(1-2):97-106. doi: 10.1016/j.aca.2011.09.021. Epub 2011 Sep 22.
In the present study, five different classes of small hydrophobic molecular targets, atypical for antibody generation, were structurally modified in order to introduce suitable reactive functionalities and/or spacers which allow covalent coupling to a carrier protein resulting in a stable carrier-hapten complex. These targets were chosen to serve as markers of extant and/or extinct life in the context of the development of the Life Marker Chip (LMC), an antibody-based instrument, which is being developed by a UK-led international consortium for flight to Mars on board the joint ESA/NASA Mars exploration ExoMars mission. The hapten-protein conjugates were designed to be used as immunogens for antibody generation and immunoassay reagents in subsequent stages of the LMC development. The extent of protein modification due to covalent attachment of hapten was determined by two independent methods, i.e. trinitrobenzenesulfonic acid (TNBSA) titrations of remaining protein reactive groups and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) of the resultant hapten-protein conjugates. In a further quality validation step, the conjugates were presented to an animal's immune system and polyclonal antibody titres with moderate specificity were obtained. These results suggest that conjugates synthesized as described herein can successfully be used in the generation of antibodies targeting small hydrophobic molecules.
在本研究中,对五类不同的小分子疏水靶标进行了结构修饰,这些靶标以前没有用于产生抗体,目的是引入合适的反应性功能基团和/或间隔基,从而能够与载体蛋白发生共价偶联,形成稳定的载体-半抗原复合物。这些靶标被选择作为现存和/或已灭绝生命的标志物,用于开发生命标志物芯片(LMC)。该芯片是由一个英国领导的国际财团开发的,用于在联合 ESA/NASA 火星探索 ExoMars 任务中飞向火星的飞行任务。半抗原-蛋白缀合物的设计目的是用作抗体产生的免疫原,并在 LMC 开发的后续阶段用作免疫测定试剂。通过两种独立的方法确定了由于半抗原的共价连接而导致的蛋白修饰程度,即三硝基苯磺酸(TNBSA)滴定法测定剩余蛋白反应基团和基质辅助激光解吸/电离质谱法(MALDI-MS)测定所得半抗原-蛋白缀合物。在进一步的质量验证步骤中,将缀合物呈递给动物的免疫系统,获得了具有中等特异性的多克隆抗体效价。这些结果表明,如本文所述合成的缀合物可以成功地用于产生针对小分子疏水靶标的抗体。